Harveycorp Life Science Portfolio

JLL’s Capital Markets Team is pleased to offer for sale a 100% freehold interest in the HarveyCorp Life Science Portfolio, a set of two best-in-class life science properties, ideally located within an existing life science node in the city Ville-Saint-Laurent (VSL) as well as in the city of Lévis which is experiencing significant demographic growth.

The Portfolio includes highly captive and vested, strong covenant tenants, with a WALT of 10.5 years. The tenant mix is primarily comprised of Contract Research Organisations (CRO) which have transformed their spaces into highly specialized laboratories which are not dependent on venture capital.

The property 4800 Dobrin, is in the heart of Ville-St-Laurent, Montreal’s most prosperous and sought-after borough, located within an established life-science node: Nexus 40-13 parc. Surrounded by a diversified amenity base, the Nexus parc is home to several corporate and life science compagnies such as Intellisyn, BridgeBio, McKesson, Paraza, Nuchem, Dynacare, Thales and others.

Located in Lévis, 480 Perreault is just south of Quebec City, and is fully leased to Omegachem, a CRO, with a remaining lease term of 12 years. The property also includes an additional parcel of land slated for future expansion and development which is currently in discussion with the tenant experiencing high growth.

The Portfolio represents a rare opportunity of scale to acquire two well leased life science

properties in great sub-markets, below replacement cost.